Specialized subsets of CD8+ T cells, specifically CD39 + PD-1 + CD8+ T cells, are prevalent in dormant tumor microenvironments and are essential for sustaining metastatic dormancy, especially in breast cancer models. This evidence concerns the gene CD8A and breast cancer.